Home » Topics » Briefs » Other news to note

Other news to note
RSS

Progene Partners dissolved upon completion of goals

May 10, 1996

OncoRx gets new identity: Vion Pharmaceuticals

May 3, 1996

Sandoz to acquire Imutran

May 3, 1996

Bristol-Myers Squibb opens R&D office in Russia

May 3, 1996

Hafslund Nycomed demerger imminent

May 3, 1996

BMS-193884 in development for heart failure

April 26, 1996

BMS-191095 in phase I for ischemia

April 26, 1996

BMS's ACE/NEP inhibitors in phase I

April 26, 1996

Phytera to acquire Neptune

April 26, 1996

Ciba-Geigy & Sandoz shareholders approve merger

April 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 6, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 6, 2024.
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...
Sanofi bets on Resalis’ oligonucleotide RES-010 for obesity
BioWorld
After missing out on the glucagon-like peptide 1 obesity market, Sanofi SA is prospecting for next-generation drugs and is making a strategic equity investment in...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.